 Hidradenitis Suppurativa
"Hidradenitis Suppurativa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.
| Descriptor ID |
D017497
|
| MeSH Number(s) |
C01.252.825.420 C01.539.800.720.420 C01.539.830.499 C17.800.838.765.420 C17.800.946.315.320
|
| Concept/Terms |
Hidradenitis Suppurativa- Hidradenitis Suppurativa
- Hidradenitides, Suppurative
- Suppurative Hidradenitides
- Suppurative Hidradenitis
- Acne Inversa
- Acne Inversas
- Inversa, Acne
- Inversas, Acne
- Hidradenitis, Suppurative
|
Below are MeSH descriptors whose meaning is more general than "Hidradenitis Suppurativa".
Below are MeSH descriptors whose meaning is more specific than "Hidradenitis Suppurativa".
This graph shows the total number of publications written about "Hidradenitis Suppurativa" by people in this website by year, and whether "Hidradenitis Suppurativa" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 | | 2013 | 1 | 0 | 1 | | 2016 | 2 | 0 | 2 | | 2017 | 3 | 0 | 3 | | 2018 | 2 | 0 | 2 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hidradenitis Suppurativa" by people in Profiles.
-
Gupta MA, Vujcic B, Sheridan AD, Gupta AK. Reduced risk of suicidal behaviours associated with the treatment of hidradenitis suppurativa with tumour necrosis factor alpha antagonists: results from the US FDA Adverse Events Reporting System pharmacovigilance database. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):1564-1568.
-
Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Nielsen SM, Christensen R, Garg A, Jemec GBE. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process. Br J Dermatol. 2018 09; 179(3):642-650.
-
Thorlacius L, Garg A, Ingram JR, Villumsen B, Theut Riis P, Gottlieb AB, Merola JF, Dellavalle R, Ardon C, Baba R, Bechara FG, Cohen AD, Daham N, Davis M, Emtestam L, Fernández-Peñas P, Filippelli M, Gibbons A, Grant T, Guilbault S, Gulliver S, Harris C, Harvent C, Houston K, Kirby JS, Matusiak L, Mehdizadeh A, Mojica T, Okun M, Orgill D, Pallack L, Parks-Miller A, Prens EP, Randell S, Rogers C, Rosen CF, Choon SE, van der Zee HH, Christensen R, Jemec GBE. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II. Br J Dermatol. 2018 03; 178(3):715-721.
-
Kanni T, Argyropoulou M, Spyridopoulos T, Pistiki A, Stecher M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ. MABp1 Targeting IL-1a for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study. J Invest Dermatol. 2018 04; 138(4):795-801.
-
Jones D, Banerjee A, Berger PZ, Gross A, McNish S, Amdur R, Shanmugam VK. Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis. Immunol Invest. 2018 Jan; 47(1):57-70.
-
Thorlacius L, Ingram JR, Garg A, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Christensen R, Jemec GB. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes. BMJ Open. 2017 02 20; 7(2):e014733.
-
Banerjee A, McNish S, Shanmugam VK. Interferon-gamma (IFN-?) is Elevated in Wound Exudate from Hidradenitis Suppurativa. Immunol Invest. 2017 Feb; 46(2):149-158.
-
Tzanetakou V, Kanni T, Giatrakou S, Katoulis A, Papadavid E, Netea MG, Dinarello CA, van der Meer JWM, Rigopoulos D, Giamarellos-Bourboulis EJ. Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial. JAMA Dermatol. 2016 Jan; 152(1):52-59.
-
Iorio ML, Rebowe RE, Hannan C. Morbidity after surgical treatment of hidradenitis suppurativa: reconstruction of severe genital lymphedema. Am Surg. 2013 Sep; 79(9):e303-4.
-
Good LM, Francis SO, High WA. Scrotal elephantiasis secondary to hidradenitis suppurativa. J Am Acad Dermatol. 2011 May; 64(5):993-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|